abstract |
It provides the antibody etc. which have a cancerous and / or tumor cell proliferation inhibitory activity of a cell. Antibodies that recognize epitopes recognized by the antibodies produced by hybridoma SH348-1 (FERM BP-10836) or hybridoma SH357-1 (FERM BP-10837), hybridoma SH348-1 or hybridoma SH357 Providing the antibody which humanized the antibody which -1 produces | generates, the antibody produced | generated by hybridoma SH348-1 or the hybridoma SH357-1, the medicine containing this antibody as an active ingredient, etc. are provided. |